Venous thrombosis associated with pancreatic cancer
Introduction. Cancer-associated thrombosis is a significant prognostic marker in pancreatic neoplasia, with a venous thromboembolism incidence of 17-34%. This study focuses on cancer-associated thrombosis risk factors, screening scores, and treatment options. Materials and Methods. Comprehensive dat...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-04-01
|
| Series: | Journal of Mind and Medical Sciences |
| Subjects: | |
| Online Access: | https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1457&context=jmms |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849702903456989184 |
|---|---|
| author | Vlad Buică Camelia Cristina Diaconu Octavian Andronic |
| author_facet | Vlad Buică Camelia Cristina Diaconu Octavian Andronic |
| author_sort | Vlad Buică |
| collection | DOAJ |
| description | Introduction. Cancer-associated thrombosis is a significant prognostic marker in pancreatic neoplasia, with a venous thromboembolism incidence of 17-34%. This study focuses on cancer-associated thrombosis risk factors, screening scores, and treatment options. Materials and Methods. Comprehensive database searches were conducted across Web of Science, PubMed, Reaxys, ScienceDirect, and Scopus. Results. Of the 37 articles reviewed, findings include splanchnic vein thrombosis correlating with pancreatic complications and survival rates. Gender differences in cancer-associated thrombosis risk were inconclusive, while African Americans showed a higher incidence of pulmonary embolism. Various cancer-associated thrombosis staging scores were evaluated, with ONKOTEV score outperforming Khorana. Direct oral anticoagulants were suggested as viable alternatives to low molecular weight heparins. Non-anticoagulant sulfated low molecular weight heparin emerged as a future option, offering reduced bleeding risks with similar efficacy. Conclusions. Managing cancer-associated thrombosis in pancreatic cancer is challenging, highlighting the need for improved understanding, better screening methods, and more effective treatments. |
| format | Article |
| id | doaj-art-1044de4c09324335b16e1a10320eca91 |
| institution | DOAJ |
| issn | 2392-7674 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Mind and Medical Sciences |
| spelling | doaj-art-1044de4c09324335b16e1a10320eca912025-08-20T03:17:27ZengMDPI AGJournal of Mind and Medical Sciences2392-76742024-04-01111424810.22543/2392-7674.1457Venous thrombosis associated with pancreatic cancerVlad Buică0Camelia Cristina Diaconu1Octavian Andronic2Carol Davila University of Medicine and Pharmacy, Faculty of General Medicine, Bucharest, RomaniaCarol Davila University of Medicine and Pharmacy, Faculty of General Medicine, Bucharest, RomaniaCarol Davila University of Medicine and Pharmacy, Faculty of General Medicine, Bucharest, RomaniaIntroduction. Cancer-associated thrombosis is a significant prognostic marker in pancreatic neoplasia, with a venous thromboembolism incidence of 17-34%. This study focuses on cancer-associated thrombosis risk factors, screening scores, and treatment options. Materials and Methods. Comprehensive database searches were conducted across Web of Science, PubMed, Reaxys, ScienceDirect, and Scopus. Results. Of the 37 articles reviewed, findings include splanchnic vein thrombosis correlating with pancreatic complications and survival rates. Gender differences in cancer-associated thrombosis risk were inconclusive, while African Americans showed a higher incidence of pulmonary embolism. Various cancer-associated thrombosis staging scores were evaluated, with ONKOTEV score outperforming Khorana. Direct oral anticoagulants were suggested as viable alternatives to low molecular weight heparins. Non-anticoagulant sulfated low molecular weight heparin emerged as a future option, offering reduced bleeding risks with similar efficacy. Conclusions. Managing cancer-associated thrombosis in pancreatic cancer is challenging, highlighting the need for improved understanding, better screening methods, and more effective treatments.https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1457&context=jmmspancreatic cancervenous thromboembolismonkotev scorelow molecular weight heparin |
| spellingShingle | Vlad Buică Camelia Cristina Diaconu Octavian Andronic Venous thrombosis associated with pancreatic cancer Journal of Mind and Medical Sciences pancreatic cancer venous thromboembolism onkotev score low molecular weight heparin |
| title | Venous thrombosis associated with pancreatic cancer |
| title_full | Venous thrombosis associated with pancreatic cancer |
| title_fullStr | Venous thrombosis associated with pancreatic cancer |
| title_full_unstemmed | Venous thrombosis associated with pancreatic cancer |
| title_short | Venous thrombosis associated with pancreatic cancer |
| title_sort | venous thrombosis associated with pancreatic cancer |
| topic | pancreatic cancer venous thromboembolism onkotev score low molecular weight heparin |
| url | https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1457&context=jmms |
| work_keys_str_mv | AT vladbuica venousthrombosisassociatedwithpancreaticcancer AT cameliacristinadiaconu venousthrombosisassociatedwithpancreaticcancer AT octavianandronic venousthrombosisassociatedwithpancreaticcancer |